U.S. markets close in 2 hours

AbbVie Inc. (ABBV)

NYSE - Nasdaq Real Time Price. Currency in USD
138.76+0.68 (+0.49%)
As of 02:00PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Short-term KST

Short-term KST

Previous Close138.08
Bid138.78 x 800
Ask138.80 x 1000
Day's Range137.65 - 139.08
52 Week Range130.96 - 168.11
Avg. Volume4,788,853
Market Cap244.989B
Beta (5Y Monthly)0.48
PE Ratio (TTM)38.02
EPS (TTM)3.65
Earnings DateFeb 07, 2024 - Feb 12, 2024
Forward Dividend & Yield6.20 (4.49%)
Ex-Dividend DateJan 12, 2024
1y Target Est169.72
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
-19% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for ABBV

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • AbbVie Inc.
    Analyst Report: AbbVie IncAbbVie, a research-based biopharmaceutical company, was spun off from Abbott Laboratories in January 2013. The company is based in suburban Chicago. The shares are a component of the S&P 500.
    Fair Value
    Economic Moat
    26 days agoArgus Research
View more